Healthtech Startups

Caspar develops a privacy-first Physical AI platform that processes continuous real-world data to help healthcare care teams intervene earlier and deliver proactive care at scale, particularly for vulnerable populations.

1 investor

Cassini Technologies develops digital cataract and refractive surgery solutions using corneal measurement technology and registration algorithms for surgical guidance. The company provides advanced corneal diagnostics and surgical planning tools for eye surgeons.

1 investor

Castor provides a clinical trial data platform that combines electronic data capture, AI-assisted source data extraction with human review, and real-world evidence collection for medical device manufacturers, biopharma, diagnostics, and academic research teams. The platform connects siloed trial data and reduces manual data handling to accelerate the path from research to patient treatment.

1 investor

Catalera develops biopesticide solutions using patented formulation technology for biological active ingredients. The company offers fungicides, insecticides, and miticides registered for use across consumer, professional, and agricultural applications in the United States.

1 investor

Catapult develops wearable tracking devices and software for athlete and team performance monitoring across professional and amateur sports. The company serves teams and athletes in 40+ sports globally, providing solutions for tracking, athlete management, and video analysis.

1 investor

A contract research organization (CRO) that provides clinical trial and regulatory services to pharmaceutical sponsors. Catawba Research leverages scientific and regulatory expertise to support drug development programs across multiple therapeutic areas.

1 investor

Caterna offers a digital therapy for children with amblyopia (lazy eye), combining occlusion with its patented FAVAS (Focal Ambient Visual Acuity Stimulation) to train the weaker eye through games played at home on a tablet, laptop, or computer. Developed at the Technical University of Dresden, it is a CE-certified Class 1 medical device prescribed by physicians and used alongside teleophthalmology support.

1 investor

Caterpillar Health provides a workplace wellness program that lets companies set up a health community where employees earn points for completing goals and challenges, which can be redeemed for rewards at over 100 UK retailers. Its approach draws on behavioural science techniques to help members build lasting healthy habits.

1 investor

CathBuddy develops a reusable intermittent catheter system for people with spinal cord injuries and other catheter users, aiming to reduce single-use catheter waste and support patient independence. Its FDA-authorized system is planned for sale through select Veterans Health Administration spinal cord injury hospitals.

1 investor

CathVision develops electrophysiology solutions for physicians treating cardiac arrhythmia, including the ECGenius EP recording system for cardiac signal acquisition and Cardialytics AI-based analytic tools. Its products support the diagnosis, characterization, and treatment of heart rhythm disorders in the EP lab.

1 investor

CatSci is a contract research organization (CRO) providing drug development services — including catalyst screening, process chemistry, analytical development, oligonucleotides, peptides, and bioscience — to help biotech and pharma companies advance complex synthetic medicines from discovery to IND. It operates 14 laboratories across the UK and Europe and serves more than 100 biotech and global pharma customers.

1 investor

Cbio develops next-generation T-cell therapies for solid tumors, which account for the majority of cancers. Its lead product, novoleucel, is a minimally invasive cell therapy designed to improve clinical outcomes and survival for late-stage cancer patients.

1 investor

Illumia builds technology for access control, dining, and payments used across education, healthcare, and corporate enterprise environments. Its systems support tasks such as secure building entry, nutrition-based meal ordering, and cashless purchases for the organizations it serves.

1 investor

CBSET is a preclinical research organization providing in vivo evaluation and development services for novel medical devices, drugs, and cell-based therapeutics, along with histopathology, morphometry, and physician training. It serves medical device and biotech companies from its facility in Waltham, Massachusetts.

1 investor

CC Bio develops synthetic biology-based therapeutics to treat microbiome-related diseases by engineering and editing the microbiome with precision. The company uses its proprietary Zeus platform to discover and optimize first-in-class treatments for patients seeking alternatives to antibiotics.

1 investor

The company produces cosmetic covers (silicone-like coverings) for lower-limb prostheses, serving amputees and prosthetic centers in Russia. Customers can obtain the covers via a state electronic certificate through the Gosuslugi portal or by ordering directly through their prosthetic center.

1 investor

The CDC Foundation is a nonprofit authorized by Congress that mobilizes philanthropic and private-sector resources to support the Centers for Disease Control and Prevention's public health mission. It manages hundreds of programs across the United States and 77 countries addressing chronic diseases, infectious diseases, and emergency health responses.

1 investor

Cebina is an early-stage biotech investor and incubator that funds and de-risks pre-company and startup drug development projects across pre-seed, seed, and Series A stages. It focuses on therapeutic areas including cardiovascular and metabolic diseases, lung fibrosis, cancer immunotherapy, and anti-infectives, and also pursues co-development and licensing partnerships.</parameter> <parameter name="founders">[]

1 investor

Cedar Health Research operates clinical research services for community-based healthcare providers, connecting patient populations with clinical trials through partnerships and EMR abstraction technology. The company aims to ensure clinical trial participants reflect the broader patient population bearing disease burden.

1 investor

Celea develops deupirfenidone, a pulmonary therapeutic targeting idiopathic pulmonary fibrosis in partnership with physicians and patient advocacy organizations.

1 investor

Cell Invent develops human disease models using reprogrammed Alzheimer patient cells to identify new therapeutic approaches for Alzheimer's disease. The company applies proprietary cellular research technology from Lund University to drug discovery and disease modeling for the neurodegenerative disease market.

1 investor

Cell-Easy is a contract development and manufacturing organization (CDMO) specialized in process development and GMP manufacturing of cell therapies and Advanced Therapy Medicinal Products (ATMPs), including T-cells, NK cells, MSCs, and iPSCs. It serves academic laboratories, biotech, and pharma companies from early development through clinical-stage manufacturing.

1 investor

CellaraRx develops Horizen, a platform that uses single-cell RNA sequencing, digital pathology, and AI to help clinicians and drug developers predict patient response to cancer treatments before clinical trial enrollment. The platform identifies tumor resistance mechanisms and tissue drug accessibility to improve patient stratification and trial success rates.

1 investor

CellaVision is a provider of digital hematology microscopy solutions including analyzers, instruments, reagents, and software that automate workflow in hematology laboratories. The company serves clinical and veterinary laboratories globally with digital cell morphology tools to minimize human error and streamline data management.

1 investor